# Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

Article · Mikhail Kosiborod, John Eric Deanfield, Richard E. Pratley, Barry A. Borlaug, Javed Butler, Melanie Jane Davies, Scott S. Emerson, Steven E. Kahn, Dalane W. Kitzman, Ildiko Lingvay, Kenneth W. Mahaffey, Mark Colquhoun Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, Sanjiv Jayendra Shah, Subodh Verma, Peter Weeke, Abraham Michael Lincoff

- Archive id: doi:10.1016/s0140-6736(24)01643-x
- Published: 2024-08-30
- Venue: The Lancet
- DOI: https://doi.org/10.1016/s0140-6736(24)01643-x
- PMID: 39222642
- Citations: 313
- Source URL: https://doi.org/10.1016/s0140-6736(24)01643-x
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.